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Abstract
Prion diseases are fatal, transmissible neurodegenerative diseases of the central nervous system. An abnormally protease-
resistant and insoluble form (PrP
Sc) of the normally soluble protease-sensitive host prion protein (PrP
C) is the major
component of the infectious prion. During the course of prion disease, PrP
Sc accumulates primarily in the lymphoreticular
and central nervous systems. Recent studies have shown that co-infection of prion-infected fibroblast cells with the
Moloney murine leukemia virus (Mo-MuLV) strongly enhanced the release and spread of scrapie infectivity in cell culture,
suggesting that retroviral coinfection might significantly influence prion spread and disease incubation times in vivo. We
now show that another retrovirus, the murine leukemia virus Friend (F-MuLV), also enhanced the release and spread of
scrapie infectivity in cell culture. However, peripheral co-infection of mice with both Friend virus and the mouse scrapie
strain 22L did not alter scrapie disease incubation times, the levels of PrP
Sc in the brain or spleen, or the distribution of
pathological lesions in the brain. Thus, retroviral co-infection does not necessarily alter prion disease pathogenesis in vivo,
most likely because of different cell-specific sites of replication for scrapie and F-MuLV.
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Introduction
Prion diseases, also known as transmissible spongiform enceph-
alopathies (TSEs), are fatal, neurodegenerative diseases that
include Creutzfeldt-Jakob disease (CJD) in humans, scrapie in
sheep, bovine spongiform encephalopathy (BSE) in cattle, and
chronic wasting disease in deer and elk. Prion diseases are
characterized by the conformational conversion of the normally
soluble, protease-sensitive cellular prion protein (PrP
C) into an
abnormal detergent-insoluble and partially protease resistant
isoform called PrP
Sc. PrP
Sc has been found to be tightly associated
with prion infectivity and recent evidence has shown that PrP
Sc is
the major component of the prion infectious agent [1,2].
PrP
C is a cell-surface glycoprotein expressed in various
mammalian tissues including brain, spinal cord, nerve, heart,
muscle, spleen and lymph node (for review see [3]). Thus, even
though the major pathological hallmarks of prion disease are
spongiform degeneration and gliosis in the brain, prion infection
and the conversion of PrP
C to PrP
Sc are not necessarily restricted
to brain areas but can also occur in peripheral lymphoid tissues
such as spleen and lymph nodes [4]. The conversion of PrP
C to
PrP
Sc [5] and the spread of the prion agent from peripheral sites of
infection to the brain and vice versa [4,6–10] are key events in the
pathogenesis of prion diseases. However, in some pathological
contexts such as inflammation, prion infectivity and PrP
Sc can be
found in tissues that are not normally associated with prion
infection [11–13]. Indeed, chronic inflammatory conditions such
as nephritis, hepatitis or mastitis can lead to changes in the
distribution of scrapie infectivity in the organism although the
mechanisms involved are poorly understood [11–13].
Recently, we found that co-infection of scrapie-infected mouse
fibroblast cells with the Moloney Murine Leukemia retrovirus
(Mo-MuLV) strongly enhanced the release and spread of scrapie
infectivity in cell culture. Specifically, we found that PrP
Sc and
infectivity were associated with Mo-MuLV viral particles as well as
exosomes and observed that Mo-MuLV infection strongly
stimulated the release of exosomes [14]. In agreement with our
findings, the small-ruminant caprine arthritis encephalitis lentivi-
rus (CAEV) was also found to enhance PrP
Sc accumulation in co-
infected, cultured sheep microglial cells as well as culture
supernatant [15]. Similarly, Ligios et al. showed that the lentivirus
Maedi Visna virus, a common cause of lymphofollicular mastitits
in sheep, leads to an inflammatory response which is associated
with an increase in prion propagation and secretion of prions into
milk [13]. Taken together, the data suggest that retroviral co-
infection might facilitate the spread of prions in vivo by
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30872significantly increasing the level of PrP
Sc released from infected
tissues. If this hypothesis is correct, then peripheral co-infection of
a mouse with scrapie and the Mo-MuLV retrovirus would lead to
a more rapid spread of scrapie infectivity and shorter scrapie
disease incubation times.
When inoculated peripherally, the most commonly used strains
of mouse scrapie have disease incubation times in excess of 6
months. Mo-MuLV is a highly pathogenic mouse retrovirus which
causes a fatal T-cell lymphoma 3–5 months after inoculation into
susceptible newborn mice [16]. Thus, co-infected mice might
succumb to T-cell lymphoma before they became clinically ill with
scrapie. To address the issue of whether or not retroviral infection
of a mouse would alter prion pathogenesis, murine Friend
leukemia retrovirus (F-MuLV) was substituted for Mo-MuLV. F-
MuLV and spleen focus-forming virus (SFFV) together form the
pathogenic Friend virus complex (FV) [17] which infects adult
immunocompetent mice [18]. Co-infection with mouse scrapie
and FV has been done before using mice highly susceptible to
Friend virus-induced leukemia [19] with no effect on scrapie.
However, this lack of effect might have been due to lack of virus
early during prion infection since the mice were infected with FV
months after being infected with murine scrapie. In order to
ensure that actively replicating virus would be present for the
entire course of prion infection, we used a mouse strain, (C57BL/
106A.BY)F1, that becomes highly viremic during the first weeks
of acute FV infection but which then mounts strong immune
responses and recovers without the development of leukemia [18].
Importantly, following the immune-mediated resolution of the
acute FV infection, infectious virus still persists at detectable levels
in the spleen for the lifetime of the mouse [20]. Thus, unlike the
previous study [19], actively replicating retrovirus would be
present at high levels during the early stages of mouse prion
infection where peripheral prion replication and spread can be
critical for efficient neuroinvasion [6–10] as well as at low levels in
the spleen throughout the rest of the scrapie incubation period.
In the current study we show that, similarly to Mo-MuLV, co-
infection of mouse scrapie-infected tissue cells with F-MuLV leads
to an increase in exosomes, prion protein and scrapie infectivity in
vitro. However, peripheral co-infection of mice with 22L mouse
scrapie and FV did not lead to a decrease in scrapie disease
incubation times or any significant alterations in 22L scrapie
pathogenesis. Our results show that retroviral co-infection does not
necessarily alter prion disease pathogenesis in vivo.
Materials and Methods
Cells
Mouse NIH3T3-22L fibroblasts infected with the 22L scrapie
strain were previously described in Vorberg et al. [21] while
NIH3T3-22L/MoMuLV were previously described in Leblanc
et al. [14]. The neuroblastoma cells N2a#58 and N2a#22L were
kindly provided by Sylvain Lehmann and were described in
Nishida et al. [22]. NIH3T3-22L/FB29 and NIH3T3-22L/57 are
mouse fibroblast cells co-infected with the mouse scrapie strain
22L and the Friend murine leukemia virus (F-MuLV) strains FB29
or Fr57, respectively. NIH3T3 and N2a cells were maintained in
DMEM or OptiMEM medium (Invitrogen) supplemented with
10% FCS, L-glutamine and penicillin/streptomycin, respectively.
Antibodies
Monoclonal anti-PrP antibodies SAF-32 and SAF-83 were
obtained from J. Grassi (CEA Saclay, SPIbio), 6D11 was from
Covance Research Products and D13 from InPro Technology.
The Rabbit a-Envgp70 (DJ-39462) and a-CAp30 (DJ-39461)
antibodies were kindly provided by RJ Gorelick (AIDS Vaccine
program, SAIC-Frederick). The anti-EF1a antibody (clone CBP-
KK1, ref 05-235) was purchased from Upstate cell signaling.
Reverse Transcriptase detection
Quantification of virus production was assessed by measuring
virus associated Reverse Transcriptase activity (RT) released in the
cell culture supernatant. Briefly, 10 ml of culture supernatant was
added to 50 ml of a reverse transcription mix (60 mM Tris-Cl
(pH 8), 75 mM NaCl, 0.06% Nonidet P-40 substitute (Sigma),
0.7 mM MnCl2, 6 mM dithiothreitol, 6 mg?ml
21 oligo(dT),
12 mg?ml
21 poly(rA), and 2 mCi?ml
21 [a-
32P]dTTP). After 1 h
of incubation at 37uC, 10 ml was spotted onto DEAE membrane
(DE-81; Whatman), washed 3610 minutes with 26 SSC (0.3 M
NaCl, 0.03 M sodium citrate [pH 5]) and rinsed with 100%
ethanol. The membrane was exposed to a phosphorscreen
(Molecular Dynamics) and radioactive synthesized cDNAs were
measured with a phosophorimager (Fuji), and quantified by using
MultiGauge software (Fuji).
Western blotting
NIH3T3-22L and NIH3T3-22L/F-MuLV cells were recovered
and lysed in sample buffer and boiled 5 min at 95uC. Total protein
(15 mg) was analyzed by SDS-PAGE and proteins were transferred
onto PVDF membrane (Amersham) in Tris-glycine buffer contain-
ing 20% methanol for 1.5 h at 2 mA/cm2. Membranes were
blockedfor30 minwith5%milkinTTBS(Euromedex)and probed
with antibodies directed against Envgp70, CAp30, PrP or EF1a.
After extensive washing in TTBS, membranes were incubated with
conjugated-peroxidase secondary antibodies for 1 h and then
washed for 30 min. Proteins were detected by the enhanced
chemiluminescence method (Super Signal West Pico, Pierce).
Differential centrifugation
Cell culture supernatants from NIH3T3-22L, NIH3T3-22L/
MoMuLV and NIH3T3-22L/F-MuLV cells were centrifuged
5 min at 3000 g and 5 min at 4500 g to remove cells in
suspension, ultracentrifuged 30 min at 10000 g to remove cellular
debris and finally centrifuged at 100000 g for 1 h to pellet virions
and exosomes. The resulting pellets were directly resuspended in
phosphate buffer saline (PBS) and directly loaded on N2a#58
target cells or resuspended in sample buffer and analyzed by
Western blotting using anti-Envgp70, anti-CAp30, anti-PrP or
anti-EF1a antibodies.
Coculture experiments
N2a#58 target cells were plated at a density of 2.5610
5 cells on
the growth surface of a six-well plate. For insert co-cultures,
NIH3T3-22L, NIH3T3-22L/MoMuLV and NIH3T3-22L/F-
MuLV cells were plated at 2.5610
5 cells onto the growth surface
of a 4.2 cm
2 membrane with high density pores of 0.4 mm
diameter (Becton Dickinson). Contact between cells was for 4 days
followed by passage of the target cells for 2 weeks (5 passages).
Cell blot assay
To detect the proteinase K (PK) resistant PrP, N2a#58 target
cells were transferred and blotted onto a nitrocellulose membrane
using a homemade cell blot apparatus. Detection of PrP
Sc was
performed as previously described [14,23]. The PK-treated
membrane was analyzed using a mixture of antibodies (SAF32+
SAF83) and a secondary antibody labelled with HRP (Dako).
N2a#58 and scrapie infected N2a#22L were used as negative
and positive controls for PrP
Sc, respectively.
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The F1 cross of C57BL/106 A.BY mice [(B10 X A.BY)F1]
were first infected intravenously (i.v.) via the retro-orbital route
with 500 ml of a lactate dehydrogenase-elevating virus-free stock of
Friend virus complex (FV) [18] which had been diluted 1:10 in
PBBS:2% FBS. The titer of the FV complex was 2610
5 FFU/ml
of F-MuLV and 2610
3 SFFU/ml of spleen focus-forming virus.
Immediately following the F-MuLV inoculation, (B10 X A.BY)F1
mice were inoculated intraperitoneally (i.p.) with 50 ul of a 10%
22L brain homogenate stock diluted to 1% in PBBS:2% FBS. The
i.p. titer of the 22L brain homogenate used was 2610
5.3 ID50/g.
Rocky Mountain Laboratories (RML) is an Association for
Assessment of Laboratory Animal Care (AALAC)-accredited
facility and all animal procedures were carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health (NIH). The protocol used was approved by the RML
Animal Care and Use Committee and the NIH (protocol #2006-
34). All procedures were done under isoflurane anesthesia and all
efforts were made to minimize distress.
Quantification of tissue PrP-res levels
Dilutions of a pool of 22L+FV brain homogenate were used as a
standard curve to determine the relative PrP
Sc content of
individual infected mice. Briefly, brains were homogenized in
phosphate buffered saline (PBS) by probe sonication for
10610 secs on ice. Homogenates were diluted to 0.1% brain in
PBS and digested with 20 mg/ml PK at 37uC for 60 min. PK
digested samples were separated by SDS-PAGE and transferred to
PVDF membrane for western blot analysis using the anti-PrP
monoclonal antibody 6D11 (1:5,000) followed by an anti-mouse
IgG horseradish peroxidase conjugated sheep secondary antibody
(1:400,000, GE Healthcare) and chemiluminescent development
using the ECL Advance kit (GE Healthcare). All film exposures
were scanned using a Microtek scanner at 600 dpi in grayscale
mode. The resulting tiff image was converted to a gel file and
rectangles were drawn on the image to encompass all three PrP
Sc
glycoforms in each lane along with a rectangle in an adjacent
blank area to determine background. The signal intensity in each
lane was quantified using the program ImageQuant 5.2 and the
resultant data were plotted in Excel. The Trendline function was
used to fit a curve to the data and yield an equation for
interpolating points. The Logarithmic function gave the best fit
with R
2 values.0.99.
Histology
Paraffin-embedded mouse brain and spleen sections were de-
paraffinized and stained with hemotoxylin and eosin. For
detection of PrP
Sc, slides were immersed in 10 mM sodium citrate
buffer pH 6.0 at 120uC/20psi for 20 minutes (hydrated autoclav-
ing). Slides were exposed overnight at 4uC to the anti-PrP
antibody D13 diluted 1:500 in 1% normal goat serum. Secondary
antibody was biotinylated anti-human IgG (Jackson Laboratories)
diluted 1:500 in 1% normal goat serum and was applied on a
Ventana NexES automated stainer and developed using alkaline
phosphatase conjugated streptavidin (Biogenex) and the Ventana
Fast Red chromagen.
Flow cytometric analysis
Four (B10 X A.BY)F1 mice were inoculated retro-orbitally with
FV as described above. At 7 days post-infection, follicular
dendritic cells (FDCs) were obtained from spleens dissociated in
a 6 well plate with a 100 mm nylon mesh cell strainer (Fisher
Scientific) in Minimal Essential Medium (MEM, Invitrogen) plus
150 U/ml collagenase (Gibco), 1 Mm CaCl2 and 1 Mm MgCl2.
After a one hour incubation at 37uC, samples were transferred to a
50 ml conical tube and washed with MEM. Red blood cells were
lysed with ammonium chloride TRIS. The antibodies used for cell
staining were: Pacific Blue anti-NK1.1(PK136) (Biolegend); Pacific
Orange anti-CD4; FITC anti-CD3; PE anti-Gr-1; PE-Texas Red
anti-CD45R/B220 (RA3-6B2); PerCp-Cy5.5 anti-CD19 (ID3);
PE-Cy7 anti-CD11c (HL3); A700 anti-CD11b (M1/70); APC-Cy7
anti-CD8 (53-6.7); biotin anti-I-Ap followed by Qdot605 anti-SAv
(Molecular Probes), which were purchased from BD Pharmingen,
eBioscience or Invitrogen unless otherwise noted. To detect FV
infection, cells were first incubated with an antibody to the F-
MuLV glycosylated gag protein (mAb 34, hybridoma superna-
tant), followed by Cy5-goat-anti-mouse IgG2b [18]. The data were
collected using an SORP LSRII (BD Biosciences) flow cytometer
and were analyzed using FlowJo (Tree Star). The gating strategy
for the representative flow cytometric dot plot was a live gate
negative for CD11c, CD8, CD19, CD4, CD3, CD11b, Gr-1, and
positive for MHC class II and B220 as shown.
Results
F-MuLV co-infection of 22L scrapie-infected NIH 3T3 cells
Prior to co-infecting mice with both scrapie and retrovirus, we
first needed to determine whether or not F-MuLV, like MoMuLV,
could enhance the release of prion protein and scrapie infectivity
in scrapie infected tissue culture cells. NIH3T3 cells infected with
the mouse scrapie strain 22L (NIH3T3-22L cells) were co-infected
with the F-MuLV strain FB29 (NIH3T3-22L/F-MuLV cells).
Viral replication was monitored ten days after infection by
measuring the reverse transcriptase activity in the culture medium
and assaying expression of the viral capsid protein CAp30, the
Gag polyprotein precursor Pr65Gag and the envelope glycopro-
tein Envgp70. As shown in Figure 1, NIH3T3-22L cells co-
infected with F-MuLV demonstrated significant virus-associated
reverse transcriptase activity (Figure 1A) and expressed all three
viral structural proteins (Figure 1B). These data show that F-
MuLV replicated in NIH3T3-22L cells.
Increased PrP levels and prion infectivity in the medium
of NIH3T3-22L/F-MuLV cells
To determine if F-MuLV strongly enhanced the release of prion
protein into the cell culture medium, supernatants from NIH3T3-
22L cells and NIH3T3-22L cells co-infected with F-MuLV were
recovered and subjected to differential centrifugation. The final
pellets were analyzed by western blotting using antibodies directed
against PrP, CAp30/Pr65Gag and Envgp70. As shown in
Figure 1B, F-MuLV infection strongly stimulated the release of
prion protein as judged by the increased amount of PrP in material
pelleted from the medium of co-infected cells (Figure 1B, compare
lanes 3 and 4). Additionally, we found that F-MuLV significantly
increased the release of exosomes into the cell supernatant as
judged by the increased amount of the EF1a exosome marker in
the pellet derived from the centrifuged medium of co-infected cells
(Figure 1B, compare lanes 3 and 4). Similar data were obtained
using the F-MuLV strain Fr57 (Figure 1C). Thus, just as with Mo-
MuLV [14], F-MuLV co-infection of NIH3T3-22L cells stimu-
lated the release of prion protein and exosomes into the cellular
supernatant.
To determine if the increased level of PrP in the cellular
medium of NIH3T3-22L/F-MuLV cells correlated with an
increase in scrapie infectivity in the medium, scrapie-susceptible
murine neuroblastoma cells (N2a#58) were exposed to 100 K
Prion and Retroviral Co-Infection of Mice
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culture supernatant. (A) Reverse transcriptase (RT) levels in NIH3T3-22L cells alone (22L) and NIH3T3 cells coinfected with the F-MuLV strain FB29
(22L+F-MuLV). (B) NIH3T3-22L (lane 1) and NIH3T3-22L/F-MuLV cells (lane 2) were assayed for F-MuLV expression using the DJ-39462 antibody for the
viral envelope (Envgp70, Panel 1) and the DJ-39461 antibody for the viral capsid (CAp30, panel 2). PrP was detected using SAF-32 (Total PrP, panel 3)
and exosomes using anti-EF1a (panel 4). The proteins recognized are indicated on the right side of the figure. Molecular mass markers are shown on
the left side of the panel and lane numbers are indicated on the bottom of the figure. (C) NIH3T3-22L cells (mock) or NIH3T3-22L cells co-infected
with the Friend viruses Fr57 or FB29 were analyzed by western blot for F-MuLV expression as well as PrP and exosome release as in panel B. Note that
the F-MuLV Fr57 strain, like FB29, strongly enhances PrP and exosome release. Molecular mass markers are shown on the left side of the panel and
lane numbers are indicated on the bottom of the figure. The proteins recognized are indicated on the right side of the figure. (D) Coculture assay.
Uninfected target N2a#58 neuroblastoma cells grown on the bottom surface of a six well plate and a 0.4 mm pore size insert containing the 100 K
pellet from the supernatants of NIH3T3-22L, NIH3T3-22L/MoMuLV or NIH3T3-22L/F-MuLV were cocultured for 4 days. The N2a#58 target cells were
then passaged 5 times over 2 weeks and assayed for PrP
Sc. Ct=control. (E) Total PrP (-PK) and PrP
Sc (+PK) levels in N2a58 cells co-cultured with
NIH3T3-22L/MoMuLV or NIH3T3-22L/F-MuLV supernatants were analyzed by dot blot. Ct cells=22L infected and uninfected N2a#58 cells not
exposed to supernatant. Lane numbers are shown at the bottom of the panel.
doi:10.1371/journal.pone.0030872.g001
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NIH3T3-22L/F-MuLV cells. As a positive control, 100 K pellets
from the medium of NIH3T3-22L cells co-infected with Mo-
MuLV (NIH3T3-22L/Mo-MuLV cells) [14] were also tested.
After 4 days of coculture, the N2a#58 cells were passaged 5 times
to eliminate the starting inoculum, the cells were harvested, and
the presence of PrP
Sc was determined using the cell blot assay
(Figure 1D) [14]. As shown in Figure 1E, in the absence of PK
treatment, all cells expressed similar levels of PrP. However, after
PK treatment, N2a#58 cells co-cultured with the 100 K pellets
from the medium of either NIH3T3-22L/F-MuLV or NIH3T3-
22L/Mo-MuLV cells expressed higher levels of protease-resistant
PrP than cells infected with 22L alone. These results indicated that
co-infected cells contained higher levels of scrapie infectivity in the
cell medium than cells infected with 22L alone. Thus, F-MuLV
acted similarly to Mo-MuLV [14] in vitro and strongly stimulated
the release of PrP, exosomes, and scrapie infectivity into the cell
culture medium of mouse scrapie-infected cells.
FV and 22L scrapie co-infection of susceptible mice
In order to determine whether or not retroviral co-infection
could affect scrapie disease incubation times, (B10 X A.BY)F1
mice were inoculated i.p. with the 22L strain of mouse scrapie and
i.v. with a pathogenic retrovirus stock containing a complex of F-
MuLV helper virus and spleen focus-forming virus known as
Friend virus complex (FV) [18]. These mice support high levels of
virus replication but then recover and maintain long-term
persistent virus for life [24]. As expected, control mice inoculated
with FV alone recovered from retroviral infection with the only
clinical sign being moderate splenomegaly (data not shown).
Control (B10 X A.BY)F1 mice inoculated i.p. with 22L scrapie all
developed clinical scrapie with an average disease incubation time
of 25069 days. Mice inoculated with both FV and 22L scrapie
also had moderate splenomegaly post-infection and developed
clinical scrapie after 250613 days. Thus, there was no significant
difference in mean survival times between the two groups
(Figure 2). These data show that i.v. retroviral co-infection did
not affect scrapie disease incubation times.
Figure 2. Co-infection of mice with 22L scrapie and F-MuLV
does not affect scrapie disease incubation time. Survival curve of
(B10 X A.BY)F1 mice inoculated intraperitoneally (i.p.) with 22L mouse
scrapie alone (closed circles) or co-infected with 22L scrapie i.p. and FV
intravenously (i.v., open circles). dpi=days post-infection.
doi:10.1371/journal.pone.0030872.g002
Figure 3. PrP
Sc accumulates to equivalent levels in the brain
and spleen of mice infected with 22L or 22L plus F-MuLV. (A)
Western blot of PK-treated spleen homogenates from (B10 X A.BY)F1
mice either inoculated i.v. with FV alone (F-MuLV), i.p. with mouse 22L
mouse scrapie alone (22L), or co-infected with 22L mouse scrapie i.p.
and FV i.v. (22L+F-MuLV). Samples from 4 individual mice are shown for
both 22L and 22L+FV and a single sample for FV infected mice. Lanes 2–
5 show dilutions of a standard comprised of equal amounts of spleen
homogenate from individual mice inoculated with 22L+FV (Pooled
Sample) used to calculate the relative amount of PrP
Sc in the spleen of
infected mice. (B) The relative amount of PrP
Sc in each lane in (A) was
determined by quantitative comparison to a standard curve derived
from equal amounts of spleen homogenate (as shown in panel A) or
brain homogenate (data not shown) derived from individual mice
inoculated with 22L+FV.
doi:10.1371/journal.pone.0030872.g003
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Sc levels and distribution in mice co-infected with 22L
mouse scrapie and FV
Although the scrapie incubation period was not affected, it
remained possible that co-infection altered the level of PrP
Sc
accumulation. The amount of PrP
Sc present in the brains and
spleens of co-infected mice was compared to the amount of PrP
Sc
in the brains and spleens of mice infected with 22L alone. As
shown in Figure 3A, the amount of PrP
Sc present in the spleen
varied within each group, with some mice having higher levels of
PrP
Sc in the spleen at late-stage clinical disease than others. When
the amount of PrP
Sc was quantified, no significant mean difference
was seen between mice infected with 22L alone versus mice co-
infected with 22L and FV (Figure 3B). Similarly, there was no
difference between the two groups of mice in the amount of PrP
Sc
present in the brain (Figure 3B). These results are consistent with
the similar disease incubation times observed for mice infected
with 22L alone or mice infected with both 22L and FV and suggest
that FV co-infection does not lead to an increased accumulation of
PrP
Sc during mouse scrapie infection.
While replication of FV in the spleen did not appear to increase
the level of PrP
Sc in the spleen, it was possible that the distribution
of PrP
Sc was altered. Spleens from three mice infected either with
22L plus FV, 22L alone, or FV alone were stained with the anti-
PrP antibody D13 and the distribution of PrP
Sc analyzed.
Representative results are shown in Figure 4. In (B10 X
A.BY)F1 mice inoculated with 22L alone, punctate deposits of
PrP
Sc were found primarily in the white pulp in a pattern
consistent with deposition in follicular dendritic cells (Figure 4B). A
similar pattern of PrP
Sc deposition was found in mice co-infected
with 22L and FV (Fig. 4C), suggesting that FV co-infection did not
lead to a change in PrP
Sc distribution in the spleen.
Although retroviral co-infection did not affect either scrapie
disease incubation times or PrP
Sc levels at the clinical stage of
disease, it could have affected the pathology induced by scrapie
infection in the brain. The major pathological hallmark of the 22L
strain of mouse scrapie is extensive vacuolation in the cerebellum
[25]. In order to determine whether or not there was a difference
in cerebellar vacuolation in (B10 X A.BY)F1 mice co-infected with
22L and FV, the extent of vacuolation in the brains of three co-
infected mice, 22L infected mice, or FV infected mice were
analyzed. Representative results are shown in Figure 5. When
compared to mice infected with 22L scrapie alone, no difference
was seen in the extent or localization of vacuolation in the
cerebellum (Figure 5A–C) or other regions of the brain (data not
shown) of mice co-infected with 22L and FV. Similarly, no
differences in the distribution of PrP
Sc were observed in the
cerebellum (Figure 5D–F) or other brains areas (data not shown)
between control mice infected with 22L alone and mice co-
infected with 22L and FV. Thus, retroviral co-infection of 22L
scrapie-infected mice did not noticeably alter the pathology of 22L
scrapie in the brain.
Spleen follicular dendritic cells and FV infection
One possible explanation for the lack of effect from co-infection
with Friend retrovirus was that prion infection and retroviral
infection occurred in separate cell populations. Prion replication in
the spleen occurs primarily in follicular dendritic cells (FDCs) [26–
31] and can be detected as early as 1 week post-infection [4]. FV is
a gamma retrovirus that requires actively dividing cells for
replication but its replication specifically in FDCs has not been
investigated. In order to determine if FV infected spleen FDCs
during the acute stage of infection, mice were inoculated i.v. with
FV and the spleens harvested around the time of peak FV
replication 7 days later. Spleen cells were analyzed for viral
infection by flow cytometric analysis to detect cell surface
glycosylated gag using the monoclonal antibody mAb34 combined
with a set of markers to identify FDCs. FDCs have a unique cell
surface profile and express the B cell marker B220 but not the B
cell marker CD19 or other markers of dendritic cells, monocytes,
or T cells [32]. Thus, cells were analyzed by multiparameter flow
cytometry to isolate FDCs and determine whether they were
infected. During the acute phase of FV infection, viral antigen was
not detected above background levels in FDCs but was primarily
associated with B220 negative erythroid cells (Figure 6, oval).
These data suggest that there was no direct effect of FV on PrP
Sc
levels because retroviral and prion replication were not occurring
in the same cell type.
Discussion
Co-infection of mouse scrapie infected cells with F-MuLV
increased the release of both PrP and scrapie infectivity in vitro
(Fig. 1), suggesting that in vivo co-infection might increase cell-to-
cell spread of prions and thus influence disease progression. In the
early stages of prion infection, both the prion agent and virus
would replicate in the spleen with the prion agent eventually
spreading from the periphery into the central nervous system via
peripheral nerves. We hypothesized that, by increasing the
amount of PrP and infectivity released by infected cells, the
presence of virus in the spleen would enable a more rapid spread
of 22L into the brain and a shortening of prion disease incubation
times. However, our data show that co-infection of mice with both
FV and 22L has no effect on the outcome of scrapie infection.
Our results are consistent with an earlier study where Friend
virus was used to infect mice infected with scrapie [19]. However,
because FV causes leukemia in susceptible mice, these earlier
Figure 4. PrP
Sc localization in the spleen is the same in mice infected with 22L or 22L plus FV. PrP
Sc in spleens from (B10 X A.BY)F1 mice
inoculated i.v. with FV alone (A), i.p. with mouse 22L mouse scrapie alone (B), or co-infected with 22L mouse scrapie i.p. and FV i.v. (C). Sections were
stained using the anti-PrP mouse monoclonal antibody D13. Magnification=2006.
doi:10.1371/journal.pone.0030872.g004
Prion and Retroviral Co-Infection of Mice
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30872studies used mice that had been infected with FV a full two months
after being infected with scrapie. Thus, it was still possible that FV
had a minimal effect on disease progression because it was not
present early during mouse prion infection when efficient
replication in the spleen can be important for prion neuroinvasion
and spread to the brain [6,7,9]. However, our data clearly show
that, even when both scrapie and retroviral replication are
occurring concurrently in the spleen throughout the course of
infection, FV has no discernible effect on scrapie pathogenesis.
The effect of viral co-infection on prion infection can be direct
or indirect. Co-infection of prion-infected NIH 3T3 cells in vitro
with either Moloney murine leukemia virus [14] or F-MuLV
(Figure 1) can lead to an increase in PrP levels as can co-infection
of sheep scrapie-infected microglial cells with a sheep lentivirus
[15]. Furthermore, the titer of endogenous murine retroviruses in
neuroblastoma or hypothalamic cells lines can be increased or
decreased when the cells are also infected with prions [33]. Other
studies have shown that the level of endogenous retroviruses in the
CNS [34,35] or spleen [36] can be altered by scrapie infection of
mice or BSE infection of non-human primates [37]. These data all
suggest that, when present in the same cell type, prions can
influence retroviral replication and retroviruses can influence
prion replication. However, we found no evidence of FV
replication in FDCs which are the spleen cell population infected
by prions in vivo. It remains possible that co-infection of FDCs by
other viruses could modify prion infection.
Retroviral co-infection could also have had indirect effects on
prion disease. Follicular dendritic cells are reticular network-
forming cells in lymphoid follicles that retain antigen for long
periods of time for presentation to B cells, but little is known about
their ontogeny and whether they simply migrate to follicles or
divide there. Lymphotoxin a/b secreted by B lymphocytes
activates FDCs [38] and activated FDCs are important sites of
prion replication [26,30,31]. It has been suggested that lympho-
toxin a/b-triggered differentiation of FDCs is a mechanism by
which inflammation could cause prions to replicate in tissues not
normally associated with prion infection [12]. Thus, it was also
possible that FV infection could indirectly influence prion disease
progression via lymphotoxin a/b activation of FDCs. This could
lead to increased levels of PrP
Sc in the spleen during both the acute
and chronic phases of FV infection potentially decreasing prion
disease incubation times. However, we observed neither a change
in prion disease incubation time nor an increase in the levels of
FDCs or PrP
Sc in the spleens of infected mice. Our results suggest
that, at most, any indirect effect of FV on prion disease in vivo is
either too minor or too transient to have an impact on progression
to clinical disease.
Our data demonstrating that inflammation in the spleen does
not alter prion disease incubation times, brain pathology, or PrP
Sc
levels are consistent with other studies showing that inflammation
Figure 6. Analysis of follicular dendritic cells (FDCs) for Friend
virus infection. Flow cytometry was used to detect cell surface FV
glycosylated gag using the monoclonal antibody mAb34 (Viral antigen).
FDCs are B220
+ cells gated for lack of expression of CD11c, CD8, CD19,
CD4, CD3, CD11b and Gr-1, but staining positive for MHCII. The
representative plot of FDCs from an acutely infected mouse shows no
viral antigen staining above background (Naı ¨ve) levels.
doi:10.1371/journal.pone.0030872.g006
Figure 5. Vacuolation and PrPS
c deposition in the brain is the same in mice infected with 22L or 22L plus FV. (A–C) Hemotoxylin and
eosin staining of the cerebellum from (B10 X A.BY)F1 mice inoculated (A) i.v. with FV alone, (B) i.p. with mouse 22L mouse scrapie alone, or (C) co-
infected with 22L mouse scrapie i.p. and FV i.v.. Magnification=2006. (D–F) PrP
Sc deposition in the cerebellum of (B10 X A.BY)F1 mice inoculated (D)
i.v. with FV alone, (E) i.p. with mouse 22L mouse scrapie alone, or (F) co-infected with 22L mouse scrapie i.p. and FV i.v.. Sections were stained using
the anti-PrP mouse monoclonal antibody D13 following hydrated autoclaving at high pressure and temperature. Red stain indicates the presence of
PrP
Sc. Magnification=2006.
doi:10.1371/journal.pone.0030872.g005
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prion infectivity, does not affect the normal progression of prion
disease or lead to early death in mice [11,13]. By contrast,
intracerebral inoculation of mouse adenovirus at various times
post-scrapie infection significantly reduced disease incubation
times, albeit without apparently altering scrapie pathology [39].
Furthermore, inducing inflammation in the brain early during
prion infection led to a rapid and fatal neurological disease even
though PrP
Sc levels were not affected [40]. In this latter instance,
the acceleration of neurological disease in scrapie-infected mice
was likely due to the host response to acute inflammation in the
CNS rather than to an increase in prion replication [40]. When
taken together with the current study, the data suggest that prion
infected mice are much more susceptible to the detrimental effects
of viral co-infection of or damage to prion-infected CNS tissues
rather than to prion-infected peripheral tissues.
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